Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Harmony Biosciences Holdings
Harmony Biosciences Holdings
(HRMY)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Wakix
Pitolisant
2019-08-14
2026-2030
Obstructive sleep apnea
,
Narcolepsy
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pitolisant
healthy volunteers/patients
,
diabetes mellitus
,
type 1 diabetes mellitus
,
hypoglycemia
,
alcoholic intoxication
,
alcohol drinking
,
substance-related disorders
,
renal insufficiency
,
alcoholism
,
nervous system alcohol-induced disorders
,
schizophrenia
,
myotonic dystrophy
,
autism spectrum disorder
,
disorders of excessive somnolence
,
sleepiness
,
narcolepsy
,
cataplexy
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
prader-willi syndrome
,
parkinson disease
,
idiopathic hypersomnia
,
sleep wake disorders
,
parasomnias
,
problem behavior
,
restless legs syndrome
,
psychomotor agitation
,
syndrome
,
pregnancy rate
,
anhedonia
,
cognition
Losartan
hypertension
Aspartame
phenylketonurias
Clemizole
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
Phenylacetic acid
hyperkinesis
,
attention deficit disorder with hyperactivity
Zyn002
drug interactions
,
digeorge syndrome
,
syndrome
,
22q11 deletion syndrome
Gluconorm
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use